The Blue Box Biomedical Solutions

0 reviews

The Blue Box is an innovative, non-invasive medical device designed to detect breast cancer through urine analysis. Utilizing a proprietary electronic nose (eNose) and advanced artificial intelligence (AI) algorithms, it offers a pain-free, radiation-free, and cost-effective alternative to traditional screening methods. By analyzing volatile organic compounds (VOCs) in urine samples, The Blue Box identifies patterns indicative of breast cancer, providing results within approximately 30 minutes. Key Features and Functionality: - eNose Technology: The device contains a chemical sensor array that detects VOCs present in urine, which become volatile when the sample is heated. - AI Algorithm: An advanced AI system analyzes the sensor data to identify patterns associated with breast cancer, enhancing diagnostic accuracy. - Rapid Results: Delivers diagnostic outcomes in approximately 30 minutes, facilitating prompt medical consultation. - User-Friendly Design: Designed for ease of use in gynecology clinics, requiring minimal training for healthcare professionals. - Non-Invasive and Radiation-Free: Offers a comfortable and safe screening experience without the risks associated with radiation exposure. Primary Value and Problem Solved: Breast cancer is the most treatable cancer, yet it remains the leading cause of cancer-related deaths among women, with 50% of cases detected too late. Traditional screening methods, such as mammography, can be less effective for women with dense breast tissue and often involve discomfort and radiation exposure. The Blue Box addresses these challenges by providing a sensitive (88.42%) and accurate urine-based test that outperforms mammography by 15%-30%. This innovation aims to make breast cancer screening more accessible, especially for women aged 20-49 who lack reliable screening options, thereby facilitating earlier detection and treatment.